BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.4200
-0.0268 (-6.00%)
At close: Aug 28, 2025, 4:00 PM
0.4400
+0.0200 (4.76%)
After-hours: Aug 28, 2025, 7:48 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $24.66 million as of August 28, 2025. Its market cap has decreased by -63.29% in one year.
Market Cap
24.66M
Enterprise Value
12.90M
1-Year Change
-63.29%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $24.66M, a decrease of -95.73%. That is a compound annual growth rate of -48.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 26.24M | -23.52% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
| Dec 16, 2020 | 577.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |